Evidence map›Paper›PMID 28650973›Full record

ArticlePloS one2017

Interferon signaling in Peromyscus leucopus confers a potent and specific restriction to vector-borne flaviviruses.

Adaeze O Izuogu, Kristin L McNally, Stephen E Harris, Brian H Youseff, John B Presloid, Christopher Burlak, Jason Munshi-South, Sonja M Best, R Travis Taylor

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. SARS-CoV-2 virus infection ofbioRxiv : the preprint server for biology · 2026
    Article
  2. DifferentiatingInfection and immunity · 2025
    Article
  3. The known unknowns of Powassan virus ecology.Journal of medical entomology · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Role of Mammalian Reservoir Hosts in Tick-Borne Flavivirus Biology.Frontiers in cellular and infection microbiology · 2018
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Adaeze O IzuoguDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States of America.
Kristin L McNallyInnate Immunity and Pathogenesis Unit, Laboratory of Virology, Rocky Mountain Laboratories, DIR, NIAID, NIH, Hamilton, Montana, United States of America.
Stephen E HarrisThe Graduate Center, City University of New York, New York, New York, United States of America.
Brian H YouseffDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States of America.
John B PresloidDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States of America.ORCID http://orcid.org/0000-0002-3333-5400
Christopher BurlakDepartment of Surgery, University of Minnesota, Minneapolis, Minnesota, United States of America.
Jason Munshi-SouthLouis Calder Center-Biological Field Station, Fordham University, Armonk, New York, United States of America.ORCID http://orcid.org/0000-0002-8067-4341
Sonja M BestInnate Immunity and Pathogenesis Unit, Laboratory of Virology, Rocky Mountain Laboratories, DIR, NIAID, NIH, Hamilton, Montana, United States of America.
R Travis TaylorDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States of America.ORCID http://orcid.org/0000-0002-3819-8548
University of Toledo Medical Center · USFordham University · USThe Graduate Center, CUNY · USUniversity of Minnesota · US

Funding

Virus-Host Interactions: Induction and Evasion of Host Innate ImmunityZIAAI001125 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BEST, SONJA · 2010 to 2025
$28.1M
Adaptive Evolutionary Responses of White-footed Mice (Peromyscus leucopus) to UrbR15GM099055 · NIGMS · FORDHAM UNIVERSITY · PI MUNSHI-SOUTH, JASON · 2012 to 2012
$293k
Intramural NIH HHS ZIA AI001125NIGMS NIH HHS R15 GM099055
6 · The paper itself

Abstract

Tick-borne flaviviruses (TBFVs), including Powassan virus and tick-borne encephalitis virus cause encephalitis or hemorrhagic fevers in humans with case-fatality rates ranging from 1-30%. Despite severe disease in humans, TBFV infection of natural rodent hosts has little noticeable effect. Currently, the basis for resistance to disease is not known. We hypothesize that the coevolution of flaviviruses with their respective hosts has shaped the evolution of potent antiviral factors that suppress virus replication and protect the host from lethal infection. In the current study, we compared virus infection between reservoir host cells and related susceptible species. Infection of primary fibroblasts from the white-footed mouse (Peromyscus leucopus, a representative host) with a panel of vector-borne flaviviruses showed up to a 10,000-fold reduction in virus titer compared to control Mus musculus cells. Replication of vesicular stomatitis virus was equivalent in P. leucopus and M. musculus cells suggesting that restriction was flavivirus-specific. Step-wise comparison of the virus infection cycle revealed a significant block to viral RNA replication, but not virus entry, in P. leucopus cells. To understand the role of the type I interferon (IFN) response in virus restriction, we knocked down signal transducer and activator of transcription 1 (STAT1) or the type I IFN receptor (IFNAR1) by RNA interference. Loss of IFNAR1 or STAT1 significantly relieved the block in virus replication in P. leucopus cells. The major IFN antagonist encoded by TBFV, nonstructural protein 5, was functional in P. leucopus cells, thus ruling out ineffective viral antagonism of the host IFN response. Collectively, this work demonstrates that the IFN response of P. leucopus imparts a strong and virus-specific barrier to flavivirus replication. Future identification of the IFN-stimulated genes responsible for virus restriction specifically in P. leucopus will yield mechanistic insight into efficient control of virus replication and may inform the development of antiviral therapeutics.

Indexed as

AnimalsCells, CulturedDisease Models, AnimalEncephalitis, Tick-BorneEncephalitis Viruses, Tick-BorneHost-Pathogen InteractionsHost SpecificityHumansInterferon Type IMicePeromyscusReceptor, Interferon alpha-betaRNA, Small InterferingRNA, ViralSignal TransductionSTAT1 Transcription FactorInterferon Type INS5 protein, flavivirusReceptor, Interferon alpha-betaRNA, Small InterferingRNA, ViralSTAT1 Transcription FactorViral Nonstructural Proteins

Identifiers

PMID28650973
PMCPMC5484488
OpenAlexW2670192450

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.